Impact Investment Profile: Solazyme’s Renewable Oils

solazyme

Please note the publish date of this blog. Financial information, market conditions, and other data mentioned in this post may no longer be accurate or relevant.

Solazyme, Inc. (NASDAQ:SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources — petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

Solazyme, Inc., a renewable oil and bioproducts company, and Bunge Global Innovation LLC (“Bunge”), a wholly-owned subsidiary of Bunge Limited (NYSE:BG), a global agribusiness and food company, announced today they have broken ground on a 100,000 metric ton renewable oil production facility adjacent to Bunge’s Moema sugarcane mill in Brazil. Construction started on schedule and the plant is targeted to be operational in the fourth quarter of 2013. Additionally, Hildo Henz, an experienced engineer who has led major refinery projects during his career, has been appointed General Manager of the joint venture, which was formed in April 2012 and will operate under the name Solazyme Bunge Produtos Renováveis Ltda.

Mr. Henz brings over 20 years of experience in operations and management to his new role. Previously, he was the engineering director at Brenco, a Brazilian renewable energy company, where he led greenfield projects in excess of US$ 500 million. Prior to Brenco, Mr. Henz was CEO of Alberto Pasqualini – REFAP S/A, a Petrobras/Repsol joint-venture refinery in Brazil, where he led its US$ 1.3 billion expansion. He had previously served as a strategic planning manager at Petrobras in Rio de Janeiro, where he implemented new refining technologies.

“Our joint venture with Solazyme is off to a strong start and we continue to build excitement about the renewable oil product opportunities that will emerge from the partnership. Breaking ground at Moema and adding Hildo as General Manager are great indications of our joint commitment to the sugar-to-oils platform and we look forward to continued progress,” said Ben Pearcy, Managing Director of Sugar & Bioenergy and Chief Development Officer, Bunge Limited.

“We are very happy to have broken ground on our Solazyme-Bunge joint venture facility on schedule and are also greatly pleased to have brought Hildo on board to run the JV. Hildo brings an unparalleled level of expertise that will enable successful plant commissioning and operations,” said Jonathan Wolfson, CEO, Solazyme. “He is a top-tier seasoned executive who has built, overseen and launched large manufacturing bus.

Disclosure

Abacus Wealth Partners, LLC is an SEC registered investment adviser. SEC registration does not constitute an endorsement of Abacus Wealth Partners, LLC by the SEC nor does it indicate that Abacus Wealth Partners, LLC has attained a particular level of skill or ability. This material prepared by Abacus Wealth Partners, LLC is for informational purposes only and is accurate as of the date it was prepared. It is not intended to serve as a substitute for personalized investment advice or as a recommendation or solicitation of any particular security, strategy or investment product. Advisory services are only offered to clients or prospective clients where Abacus Wealth Partners, LLC and its representatives are properly licensed or exempt from licensure. No advice may be rendered by Abacus Wealth Partners, LLC unless a client service agreement is in place. This material is not intended to serve as personalized tax, legal, and/or investment advice since the availability and effectiveness of any strategy is dependent upon your individual facts and circumstances. Abacus Wealth Partners, LLC is not an accounting or legal firm. Please consult with your tax and/or legal professional regarding your specific tax and/or legal situation when determining if any of the mentioned strategies are right for you.

Please Note: Abacus does not make any representations or warranties as to the accuracy, timeliness, suitability, and completeness, or relevance of any information prepared by an unaffiliated third party, whether linked to Abacus’ website or blog or incorporated herein, and takes no responsibility for any such content. All such information is provided solely for convenience purposes only and all users thereof should be guided accordingly.

For more information about Abacus and this article, please read these important disclosures

Share:

What’s your financial archetype?

Simplify your life with a plan

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.